RESUMO
1. Chemokine expression and function was monitored in an experimental model of granulomatous tissue formation after injection of croton oil in complete Freund's adjuvant (CO/CFA) into mouse dorsal air-pouches up to 28 days. 2. In the first week, mast cell degranulation and leukocyte influx (mononuclear cell, MNC, and polymorphonuclear cell, PMN) were associated with CXCR2, KC and macrophage inflammatory protein (MIP)-2 mRNA expression, as determined by TaqMan reverse transcriptase-polymerase chain reaction. KC ( approximately 400 pg x mg protein(-1), n=12) and MIP-2 (approximately 800 pg x mg protein(-1), n=12) proteins peaked at day 7, together with myeloperoxidase (MPO) activity. Highest MIP-1alpha (>1 ng x mg protein(-1), n=12) levels were measured at day 3. 3. After day 7, a gradual increase in CCR2 and CCR5 mRNA, monocyte chemoattractant protein (MCP)-1 mRNA and protein expression was measured. MCP-1 protein peaked at day 21 (approximately 150 pg x mg protein(-1), n=12) and was predominantly expressed by mast cells. A gradual increase in N-acetyl-beta-D-glucosaminidase (NAG) activity (maximal at 28 days) was also measured. 4. An antiserum against MIP-1alpha did not modify the inflammatory response measured at day 7 (except for a 50% reduction in MIP-1alpha levels), but provoked a significant increase in MPO, NAG and MCP-1 levels as measured at day 21 (n=6, P<0.05). An antiserum to MCP-1 reduced NAG activity at day 21 but increased MPO activity values (n=8, P<0.05). 5. In conclusion, we have shown that CO/CFA initiates a complex inflammatory reaction in which initial expression of MIP-1alpha serves a protective role whereas delayed expression of MCP-1 seems to have a genuine pro-inflammatory role.
Assuntos
Quimiocina CCL2/fisiologia , Quimiocinas/biossíntese , Proteínas Inflamatórias de Macrófagos/fisiologia , Receptores de Quimiocinas/biossíntese , Animais , Quimiocina CCL2/biossíntese , Quimiocina CCL2/genética , Quimiocina CCL3 , Quimiocina CCL4 , Quimiocinas/genética , Óleo de Cróton/farmacologia , Modelos Animais de Doenças , Feminino , Adjuvante de Freund/farmacocinética , Imuno-Histoquímica , Inflamação/tratamento farmacológico , Leucócitos/imunologia , Proteínas Inflamatórias de Macrófagos/biossíntese , Proteínas Inflamatórias de Macrófagos/genética , Mastócitos/efeitos dos fármacos , Camundongos , Peroxidase/biossíntese , Peroxidase/genética , Peroxidase/fisiologia , RNA Mensageiro/efeitos dos fármacos , RNA Mensageiro/genética , RNA Mensageiro/metabolismoRESUMO
IL-13 and IL-4 are key contributors to the asthmatic phenotype. The temporal role of these cytokines in airway function, inflammation, and remodeling were assessed in a chronic murine model of Asperigillus fumigatus-induced allergic asthma. IL-13 and IL-4 protein levels were significantly elevated by 30 days after conidia challenge in A. fumigatus-sensitized mice. Furthermore, IL-13Ralpha1 mRNA expression was significantly elevated 7 days after conidia challenge and remained elevated until day 21. In contrast, IL-13Ralpha2 mRNA expression, although constitutively expressed in naive lung, was absent in the lungs of A. fumigatus-sensitized mice both before and after conidia challenge. Membrane-bound IL-4R mRNA expression was significantly elevated 7 days after conidia challenge; however, soluble IL-4R mRNA expression was increased 30 days after conidia challenge. Immunoneutralization of IL-13 between days 14 and 30 or days 30 and 38 after fungal sensitization and challenge significantly attenuated airway hyperresponsiveness, collagen deposition, and goblet cell hyperplasia at day 38 after conidia challenge; however, the effects of IL-4 immunoneutralization during the same time periods were not as marked. IFN-gamma and IL-12 release after Aspergillus Ag restimulation was elevated from spleen cells isolated from mice treated with IL-4 anti-serum compared with IL-13 anti-serum or normal rabbit serum-treated mice. This study demonstrates a pronounced therapeutic effect of IL-13-immunoneutralization at extended time points following the induction of chronic asthma. Most importantly, these therapeutic effects were not reversed following cessation of treatment, and IL-13 anti-serum treatment did not alter the systemic immune response to Ag restimulation, unlike IL-4 immunoneutralization. Therefore, IL-13 provides an attractive therapeutic target in allergic asthma.
Assuntos
Asma/imunologia , Asma/terapia , Interleucina-13/imunologia , Interleucina-13/uso terapêutico , Animais , Antígenos de Fungos/administração & dosagem , Aspergillus fumigatus/imunologia , Asma/patologia , Asma/fisiopatologia , Hiper-Reatividade Brônquica/imunologia , Hiper-Reatividade Brônquica/patologia , Hiper-Reatividade Brônquica/fisiopatologia , Doença Crônica , Colágeno/antagonistas & inibidores , Colágeno/metabolismo , Citocinas/metabolismo , Células Caliciformes/patologia , Hiperplasia , Soros Imunes/administração & dosagem , Injeções Intraperitoneais , Interleucina-13/antagonistas & inibidores , Interleucina-13/biossíntese , Subunidade alfa1 de Receptor de Interleucina-13 , Interleucina-4/antagonistas & inibidores , Interleucina-4/biossíntese , Interleucina-4/imunologia , Pulmão/imunologia , Pulmão/metabolismo , Ativação Linfocitária , Camundongos , Camundongos Endogâmicos CBA , Fibrose Pulmonar/imunologia , Fibrose Pulmonar/prevenção & controle , RNA Mensageiro/biossíntese , Receptores de Interleucina/biossíntese , Receptores de Interleucina/genética , Receptores de Interleucina-13 , Receptores de Interleucina-4/biossíntese , Receptores de Interleucina-4/genética , Baço/citologia , Baço/imunologia , Baço/metabolismo , Esporos Fúngicos/imunologia , Fatores de TempoRESUMO
OBJECTIVE AND DESIGN: This study examined the role of nitric oxide in changes in airway physiology and inflammation in a murine model of fungal allergy induced by Aspergillus fumigatus (A. fumigatus) by treatment of A. fumigatus-sensitized mice with NG-nitro-L-arginine methyl ester (L-NAME) or D-NAME (8 mg/kg; i.p.). MATERIALS AND METHODS: Female CBA/J mice received A. fumigatus antigen dissolved in incomplete Freund's adjuvant (10 mg/100 ml i.p. and s.c.) followed 2 weeks later by A. fumigatus antigens (20 mg; i.n.) and a subsequent i.t. challenge 4 days later. Airway physiology and inflammation were examined (24 to 72 h) following i.t. challenge. RESULTS: L-NAME-treated mice had lower lung nitrite levels 24 h after A. fumigatus challenge, but higher airway hyperresponsiveness and inflammation compared to D-NAME controls. Airway inflammation in the L-NAME treatment group (72 h) was characterized by a greater bronchoalveolar lavage (BAL), peribronchial eosinophilia and augmented levels of CC chemokines compared to controls. CONCLUSIONS: These findings suggest that nitric oxide is an important modulator of airway hyperresponsiveness, inflammation and C-C chemokine generation during allergic airway responses to A. fumigatus.
Assuntos
Aspergillus fumigatus/imunologia , Asma/fisiopatologia , Hiper-Reatividade Brônquica/etiologia , Quimiocinas CC/biossíntese , Eosinofilia/etiologia , Óxido Nítrico/fisiologia , Animais , Feminino , Imunoglobulina E/sangue , Camundongos , Camundongos Endogâmicos CBA , NG-Nitroarginina Metil Éster/farmacologiaRESUMO
The aim of this study was to determine whether the cytokine macrophage inflammatory protein-1 beta (MIP-1 beta) is present and functionally active in the arthritic joint. We used immunoassays and bioassays to assess the presence and function of MIP-1 beta using samples obtained from 62 arthritic patients. MIP-1 beta levels were increased in synovial fluids (SFs) from patients with osteoarthritis (OA) (18.0 +/- 8.9 ng/ml) (SD) compared to patients with rheumatoid arthritis (RA) 6.1 +/- 2.9 ng/ml) or other forms of arthritis (10.4 +/- 7.0 ng/ml) (P < 0.05). Levels of OA SF MIP-1 beta were significantly greater than OA or normal serum levels of MIP-1 beta. Anti-MIP-1 beta neutralized 28% of the chemotactic activity for monocytes found in OA SFs. Isolated OA synovial tissue fibroblasts did not constitutively produce MIP-1 beta but could be induced to express this chemokine upon exposure to tumor necrosis factor-alpha, interleukin-1 beta, or lipopolysaccharide. Synovial tissue immunohistochemical staining revealed that the main immunopositive cells in OA were the lining cells as well as vascular smooth muscle and endothelial cells. A minority of macrophages were immunopositive as well. In this study, we identify MIP-1 beta as a unique cytokine increased in OA compared to RA SF. We conclude that MIP-1 beta may play a role in the ingress of monocytes into the OA joint.
Assuntos
Artrite Reumatoide/metabolismo , Citocinas/análise , Monocinas/análise , Osteoartrite/metabolismo , Líquido Sinovial/química , Artrite/metabolismo , Células Cultivadas , Quimiocina CCL4 , Quimiocinas/análise , Quimiotaxia de Leucócito/fisiologia , Citocinas/sangue , Citocinas/imunologia , Endotélio Vascular/química , Endotélio Vascular/citologia , Fibroblastos/química , Humanos , Soros Imunes/imunologia , Técnicas Imunoenzimáticas , Proteínas Inflamatórias de Macrófagos , Monócitos/fisiologia , Monocinas/sangue , Monocinas/imunologia , Músculo Liso Vascular/química , Músculo Liso Vascular/citologia , Membrana Sinovial/química , Membrana Sinovial/citologiaRESUMO
Previous studies have shown upregulation of lung cell interleukin-6 (IL-6) production in bleomycin-induced pulmonary fibrosis. To further elucidate the regulatory mechanisms governing this disease, the effects of bleomycin on the production of the pleiotropic cytokine, IL-6, were investigated in lung endothelial cells. Rat pulmonary artery endothelial cells were treated with bleomycin at doses previously shown to be effective in upregulating cytokine production in these cells, and the conditioned media was collected and assayed for IL-6 activity. The results show that these endothelial cells constitutively produced IL-6 and that bleomycin increased the production in a time- and dose-dependent manner. Feeding rats diets deficient in n-6 fatty acids is known to ameliorate bleomycin-induced lung fibrosis. In order to examine if fatty acids could modulate IL-6 production in vitro, cells were lipid depleted and then supplemented with 18:1n-9, 18:2n-6, or 18:3n-3 fatty acids, and the effects of bleomycin on IL-6 production reexamined. This regimen resulted in significant depletion of arachidonate in the 18:1n-9 and 18:3n-3 supplemented cells, which was associated with significantly reduced IL-6 production relative to the 18:2n-6-supplemented cells, both constitutively and when stimulated with bleomycin. Preincubation with indomethacin did not significantly inhibit the production of IL-6 by all three groups of cells, nor did supplementation with a stable prostacyclin analog increase IL-6 production. These results suggest that endothelial cell IL-6 production is not directly dependent on prostacyclin or other cyclooxygenase metabolites but may require or be upregulated by 18:2n-6 and/or metabolites derived from it.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Bleomicina/farmacologia , Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/imunologia , Ácidos Graxos/metabolismo , Interleucina-6/biossíntese , Artéria Pulmonar/efeitos dos fármacos , Artéria Pulmonar/imunologia , Animais , Contagem de Células , Células Cultivadas , Endotélio Vascular/citologia , Epoprostenol/análogos & derivados , Epoprostenol/biossíntese , Epoprostenol/farmacologia , Indometacina/farmacologia , Artéria Pulmonar/citologia , RatosRESUMO
Lens-induced granulomatous uveitis was produced in brown Norway rats. To determine the role of the lipoxygenase and cyclo-oxygenase products of arachidonic acid in the modulation of granulomatous uveitis, one group of experimental animals was treated with nafazatrom, while another group was treated with nordihydroguaiaretic acid (lipoxygenase inhibitors). Both resulted in significant attenuation of granulomatous inflammation, with reduced giant-cell infiltration into the choroid. In contrast, indomethacin (a cyclo-oxygenase inhibitor) therapy resulted in increased giant-cell formation. These findings suggest that the lipoxygenase and cyclo-oxygenase products of arachidonic acid play a role in the development of granulomatous uveitis and that such inflammation can be selectively suppressed by lipoxygenase inhibitors.